Timothy N. Showalter

Radiation Oncology
1240 Lee St
Charlottesville, VA 22908

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 175 publications

Artificial Intelligence impact on decision-making regarding short-term ADT with prostate radiotherapy: ASTuTE clinical trial interim results.

Artificial Intelligence impact on decision-making regarding short-term ADT with prostate radiotherapy: ASTuTE clinical trial interim results.

Journal: Clinical and translational radiation oncology
Published: July 20, 2026

Retrieval-Augmented Generation in Oncology: Promises, Pitfalls, and Early Applications.

Retrieval-Augmented Generation in Oncology: Promises, Pitfalls, and Early Applications.

Journal: AI in precision oncology
Published: June 17, 2026

A Multimodal Artificial Intelligence Model to Guide Use of Whole-Pelvic Radiation Therapy in Patients with Localized Prostate Cancer: Exploratory Analysis of RTOG 9413.

A Multimodal Artificial Intelligence Model to Guide Use of Whole-Pelvic Radiation Therapy in Patients with Localized Prostate Cancer: Exploratory Analysis of RTOG 9413.

Journal: Cancers
Published: May 05, 2026

First Measurement: Proactively Sparing the Immune System During SBRT to Early-Stage Lung Cancer-A Randomized Phase II Study.

First Measurement: Proactively Sparing the Immune System During SBRT to Early-Stage Lung Cancer-A Randomized Phase II Study.

Journal: International journal of radiation oncology, biology, physics
Published: January 12, 2026

Combining pathology artificial intelligence and genomic biomarkers to refine long-term postprostatectomy outcome prediction.

Combining pathology artificial intelligence and genomic biomarkers to refine long-term postprostatectomy outcome prediction.

Journal: Journal of the National Cancer Institute
Published: September 25, 2025

Digital Pathology-Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate Cancer.

Digital Pathology-Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate Cancer.

Journal: JCO precision oncology
Published: January 31, 2025

A multicentre implementation trial of an Artificial Intelligence-driven biomarker to inform Shared decisions for androgen deprivation therapy in men undergoing prostate radiotherapy: the ASTuTE protocol.

A multicentre implementation trial of an Artificial Intelligence-driven biomarker to inform Shared decisions for androgen deprivation therapy in men undergoing prostate radiotherapy: the ASTuTE protocol.

Journal: BMC cancer
Published: January 29, 2025

First Measurement: Proactive Immune Cell Sparing in Radiation Therapy.

First Measurement: Proactive Immune Cell Sparing in Radiation Therapy.

Journal: medRxiv : the preprint server for health sciences
Published: January 20, 2025

Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer.

Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer.

Journal: European urology oncology
Published: November 04, 2024

Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology.

Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology.

Journal: JCO precision oncology
Published: October 24, 2024

Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer.

Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: September 11, 2024

The Importance of Multiparametric Magnetic Resonance Imaging, Positron Emission Tomography/Computed Tomography, and Biopsy for Identifying and Delineating the Extent of Intraprostatic Radiorecurrent Prostate Cancer: A Secondary Analysis of the F-SHARP Clinical Trial.

The Importance of Multiparametric Magnetic Resonance Imaging, Positron Emission Tomography/Computed Tomography, and Biopsy for Identifying and Delineating the Extent of Intraprostatic Radiorecurrent Prostate Cancer: A Secondary Analysis of the F-SHARP Clinical Trial.

Journal: International journal of radiation oncology, biology, physics
Published: July 24, 2024
Showing 1-12 of 175

Last Updated: 09/26/2026